Dr. Dante J. Pieramici, a retina specialist at California Retina Consultants, has written a comprehensive overview of current protocols for anti-VEGF treatment of neovascular age-related macular degeneration (AMD).

In his article, New Uses of Anti-VEGF Agents for the Treatment of Neovascular AMD, written for Refractive Eyecare, Dr. Pieramici discusses current approaches for boosting efficacy and the duration of anti-VEGF therapy, including the evaluation of new dosing regimens, higher drug doses, and the use of combination therapies and newer medications.

With the permission of the author and the publisher, I have reproduced his writeup in my online Journal.

The article can be viewed at this link ^[1].

In addition, I have also provided a link to a similar article just published in Ocular Surgery News, titled: Combination Therapy May Augment Anti-VEGF Activity.